U.S. pays $590 million to Moderna to speed up development of bird flu vaccine
The federal government is stepping up efforts to protect Americans from a growing threat: bird flu. With $590 million in new funding, Moderna will accelerate the development of a vaccine targeting pandemic influenza, including the unpredictable H5N1 virus. While bird flu has mostly impacted livestock, human cases are rising, with 67 confirmed infections. Outgoing HHS Secretary Xavier Becerra emphasized the urgency of staying ahead of potential outbreaks, calling it a critical priority. Public health risks remain low, but vigilance is key.
MinotVoice
MinotVoice authorship is an amalgamation of source material and local context. It is created with a human touch and an occasional AI assist. When licensing allows or content is provided as a news release, that content is also published under MinotVoice authorship and properly attributed within the article.
Subscribe!
It's free and it helps us grow and provide better information ForMinot!
Comments
Register or log in to join the conversation.